Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konaka

Showing results (341-350 of 431) with videos related to

Pageof 44
Sort By:
Internal Medicine (Tokyo, Japan)|July 10, 2024
Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing MyopathyYoshihiro Tokunaga, Masaru Akiyama, Kohei Nakano, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|December 22, 2010
Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled studyKazuyoshi Shigehara, Kazuhiro Sugimoto, Hiroyuki Konaka, et al.
Inorganic Chemistry|January 9, 2018
Contribution of Coulomb Interactions to a Two-Step Crystal Structure Phase Transformation Coupled with a Significant Change in Spin Crossover Behavior for a Series of Charged Fe<sup>II</sup> Complexes from 2,6-Bis(2-methylthiazol-4-yl)pyridineKazuyuki Takahashi, Mitsunobu Okai, Tomoyuki Mochida, et al.
Biomedical Research (Tokyo, Japan)|December 28, 2012
The effectiveness of interferon-alpha subtypes alternation for metastasis from renal cell carcinomaYoshifumi Kadono, Sotaro Miwa, Takashi Shima, et al.
Frontiers in Cardiovascular Medicine|May 25, 2026
OPCAB in the minimally invasive era: impact on wound complications-a comparative study with on-pump CABGKen Nakamura, Kentaro Akabane, Shusuke Arai, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2014
Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen levelKouji Izumi, Wen-Jye Lin, Hiroshi Miyamoto, et al.
Anticancer Research|October 15, 2013
Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanoneMitsuo Ofude, Atsushi Mizokami, Misako Kumaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 11, 2006
[Comparison of ramosetron and azasetron for prevention of acute and delayed cisplatin-induced emesis in lung cancer patients]Toru Hayakawa, Mayumi Sato, Masako Konaka, et al.
British Journal of Cancer|January 1, 1997
Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological featuresT Hirano, K Fujioka, B Franzèn, et al.
The Prostate|May 13, 2009
Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changesKouji Izumi, Atsushi Mizokami, You Qiang Li, et al.
Pageof 44

Showing results (341-350 of 431) with videos related to

Sort By:
Pageof 44
Internal Medicine (Tokyo, Japan)|July 10, 2024
Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing MyopathyYoshihiro Tokunaga, Masaru Akiyama, Kohei Nakano, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|December 22, 2010
Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled studyKazuyoshi Shigehara, Kazuhiro Sugimoto, Hiroyuki Konaka, et al.
Inorganic Chemistry|January 9, 2018
Contribution of Coulomb Interactions to a Two-Step Crystal Structure Phase Transformation Coupled with a Significant Change in Spin Crossover Behavior for a Series of Charged Fe<sup>II</sup> Complexes from 2,6-Bis(2-methylthiazol-4-yl)pyridineKazuyuki Takahashi, Mitsunobu Okai, Tomoyuki Mochida, et al.
Biomedical Research (Tokyo, Japan)|December 28, 2012
The effectiveness of interferon-alpha subtypes alternation for metastasis from renal cell carcinomaYoshifumi Kadono, Sotaro Miwa, Takashi Shima, et al.
Frontiers in Cardiovascular Medicine|May 25, 2026
OPCAB in the minimally invasive era: impact on wound complications-a comparative study with on-pump CABGKen Nakamura, Kentaro Akabane, Shusuke Arai, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2014
Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen levelKouji Izumi, Wen-Jye Lin, Hiroshi Miyamoto, et al.
Anticancer Research|October 15, 2013
Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanoneMitsuo Ofude, Atsushi Mizokami, Misako Kumaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 11, 2006
[Comparison of ramosetron and azasetron for prevention of acute and delayed cisplatin-induced emesis in lung cancer patients]Toru Hayakawa, Mayumi Sato, Masako Konaka, et al.
British Journal of Cancer|January 1, 1997
Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological featuresT Hirano, K Fujioka, B Franzèn, et al.
The Prostate|May 13, 2009
Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changesKouji Izumi, Atsushi Mizokami, You Qiang Li, et al.
Pageof 44